Evaluation of platelet function screening tests to detect platelet procoagulant deficiency in dogs with Scott syndrome

Veterinary Clinical Pathology

Volumn 38, Issue 3, 2009, Pages 306-315

  Brooks, Marjory B ^a   Randolph, John ^b   Warner, Karen ^b   Center, Sharon ^b  

^a Animal Health Diagnostic Center   (United States)

^b Department of Molecular Biology and Genetics   (United States)

Author keywords

Coagulation disorder; Disease models; P selectin; Platelet activation; Thromboelastography; Thrombopathia

Indexed keywords

CANIS FAMILIARIS;

BLOOD CLOTTING FACTOR; FIBRINOGEN; PADGEM PROTEIN; PLATELET PROCOAGULANT FACTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; DOG; DOG DISEASE; EVALUATION; FEMALE; FLOW CYTOMETRY; HOSPITAL INFORMATION SYSTEM; INSTRUMENTATION; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ANIMALS; BLOOD CELL COUNT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; DOG DISEASES; DOGS; FEMALE; FIBRINOGEN; FLOW CYTOMETRY; MALE; P-SELECTIN; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS;

EID: 70350731143     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2009.00141.x     Document Type: Article

References (39)

1. Catalfamo JL, Dodds WJ. Thrombopathias. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. 5th edition. Philadelphia, PA: Lippincott Williams and Wilkins; 2000:1042-1050.
2. Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost. 2003;1:1628-1636.
3. Brooks M. A review of canine inherited bleeding disorders: biochemical and molecular strategies for disease characterization and carrier detection. J Hered. 1999;90:112-118.
4. Boudreaux MK, Catalfamo JL. Molecular and genetic basis for thrombasthenic thrombopathia in otterhounds. Am J Vet Res. 2001;62:1797-1804.
5. Lipscomb DL, Bourne C, Boudreaux MK. Two genetic defects in alphaIIb are associated with type I Glanzmann's thrombasthenia in a Great Pyrenees dog: a 14-base insertion in exon 13 and a splicing defect of intron 13. Vet Pathol. 2000;37:581-588.
6. Boudreaux MK, Catalfamo JL, Klok M. Calcium-diacylglycerol guanine nucleotide exchange factor I gene mutations associated with loss of function in canine platelets. Transl Res. 2007;150:81-92.
7. Callan MB, Bennett JS, Phillips DK, et al. Inherited platelet delta storage pool disease in dogs causing severe bleeding: an animal model for a specific ADP deficiency. Thromb Haemost. 1995;74:949-953.
8. Brooks MB, Catalfamo JL, Brown HA, et al. A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity. Blood. 2002;99:2434-2441.
9. Zwaal RF, Comfurius P, Bevers EM. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta. 1992;1180:1-8.
10. Weiss HJ. Scott syndrome: a disorder of platelet coagulant activity. Semin Hematol. 1994;31:312-319.
11. Toti F, Satta N, Fressinaud E, et al. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood. 1996;87:1409-1415.
12. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta. 2004;1636:119-128.
13. Kottke-Marchant K, Corcoran G. The laboratory diagnosis of platelet disorders. Arch Pathol Lab Med. 2002;126:133-146.
14. Cardigan R, Turner C, Harrison P. Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang. 2005;88:153-163.
15. Shah U, Ma AD. Tests of platelet function. Curr Opin Hematol. 2007;14:432-437.
16. Michelson AD, Barnard MR, Krueger LA, et al. Evaluation of platelet function by flow cytometry. Methods. 2000;21:259-270.
17. Ritchie JL, Alexander HD, Rea IM. Flow cytometry analysis of platelet P-selectin expression in whole blood-methodological considerations. Clin Lab Haematol. 2000;22:359-363.
18. Couto CG, Lara A, Iazbik MC, et al. Evaluation of platelet aggregation using a point-of-care instrument in retired racing Greyhounds. J Vet Intern Med. 2006;20:365-370.
19. Mischke R, Keidel A. Influence of platelet count, acetylsalicylic acid, von Willebrand's disease, coagulopathies, and haematocrit on results obtained using a platelet function analyser in dogs. Vet J. 2003;165:43-52.
20. Brainard BM, Meredith CP, Callan MB, et al. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res. 2007;68:251-257.
21. Wiinberg B, Jensen AL, Rojkaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol. 2005;34:389-393.
22. Stokol T, Brooks MB, Erb HN. Effect of citrate concentration on coagulation test results in dogs. J Am Vet Med Assoc. 2000;217:1672-1677.
23. Vilar P, Couto CG, Westendorf N, et al. Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs. J Vet Intern Med. 2008;22:374-379.
24. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis. 2001;12:327-337.
25. Rukshin V, Azarbal B, Finkelstein A, et al. Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis. J Cardiovasc Pharmacol. 2003;41:615-624.
26. Tarnow I, Kristensen AT, Krogh AK, et al. Effects of physiologic agonists on canine whole blood flow cytometry assays of leukocyte-platelet aggregation and platelet activation. Vet Immunol Immunopathol. 2008;123:345-352.
27. Wills TB, Wardrop KJ, Meyers KM. Detection of activated platelets in canine blood by use of flow cytometry. Am J Vet Res. 2006;67:56-63.
28. Kirkman TW. Statistics To Use. Available at http://www.physics.csbsju.edu/stats/ (accessed July 20, 2008).
29. Wessa P. Free Statistics Software version 1.1.23-rl. Available at http://www.wessa.net/ (accessed July 20, 2008).
30. Harrison P. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol. 2005;130:3-10.
31. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med. 2001;138:152-163.
32. Callan MB, Giger U. Assessment of a point-of-care instrument for identification of primary hemostatic disorders in dogs. Am J Vet Res. 2001;62:652-658.
33. Johansson PI, Bochsen L, Andersen S, et al. Investigation of the effect of kaolin and tissue factor-activated citrated whole blood, on clot forming variables, as evaluated by thromboelastography. Transfusion. 2008;48:2377-2383.
34. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost. 2006;32(Suppl 1):32-38.
35. Rivard GE, Brummel-Ziedins KE, Mann KG, et al. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost. 2005;3:2039-2043.
36. Weiss DJ, Brazzell JL. Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia. J Vet Intern Med. 2006;20: 682-686.
37. Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost. 2005;3:2185-2192.
38. Heemskerk JW, Siljander PR, Bevers EM, et al. Receptors and signalling mechanisms in the procoagulant response of platelets. Platelets. 2000;11:301-306.
39. Brooks MB, Catalfamo JL, Friese P, et al. Scott syndrome dogs have impaired coated-platelet formation and calcein-release but normal mitochondrial depolarization. J Thromb Haemost. 2007;5:1972-1974.